Open
GenerationsE為病理學家開發了AI驅動的癌症診斷解決方案，以使他們能夠使用深度學習和數字病理學技術，最終將為患者帶來快速，準確和負擔得起的癌症診斷和治療。過去大腸鏡檢漏檢率約10%到20%，藉由AI軟體輔助，準確度可提升至95%，讓患者能獲得更精準的診斷與治療。
GenerationsE develops AI-driven cancer diagnostic solutions for pathologists in order to empower them with deep learning and digital pathology technologies and to drive the excellence of pathology which will ultimately benefit patients with fast, accurate, and affordable cancer diagnosis and treatment. We have partnered with BC Cancer, a global leading cancer research centre since 2017 and released DeepScene™ 1.0, a colorectal cancer biopsy diagnostic assistance solution for pathologists in March 2019. Currently we have a total of eight hospitals and over 100 pathologists across Canada and Taiwan partnering with us on developing DeepScene™. We also have access to over 5 million cancer biopsy slide data.
GenerationsE develops AI-driven cancer diagnostic solutions for pathologists in order to empower them with deep learning and digital pathology technologies and to drive the excellence of pathology which will ultimately benefit patients with fast, accurate, and affordable cancer diagnosis and treatment. We have partnered with BC Cancer, a global leading cancer research centre since 2017 and released DeepScene™ 1.0, a colorectal cancer biopsy diagnostic assistance solution for pathologists in March 2019. Currently we have a total of eight hospitals and over 100 pathologists across Canada and Taiwan partnering with us on developing DeepScene™. We also have access to over 5 million cancer biopsy slide data.